COMMUNIQUÉS West-GlobeNewswire

Sol-Gel Technologies Reports Second Quarter 2018 Financial Results

08/08/2018 - 13:05

NESS ZIONA, Israel, Aug. 08, 2018 (GLOBE NEWSWIRE) -- Sol-Gel Technologies Ltd. (NASDAQ: SLGL) (“Sol-Gel” or the “Company”), a clinical-stage dermatology company focused on identifying, developing and commercializing [...]

Unum Therapeutics to Present at Two Upcoming Investor Conferences

08/08/2018 - 13:00

CAMBRIDGE, Mass., Aug. 08, 2018 (GLOBE NEWSWIRE) -- Unum Therapeutics Inc. (NASDAQ:UMRX), a clinical-stage biopharmaceutical company focused on the development of cellular immunotherapies based on its novel, universal [...]

Nabriva Therapeutics to Present at the 2018 Wedbush PacGrow Healthcare Conference

08/08/2018 - 13:00

DUBLIN, Ireland and KING OF PRUSSIA, Pa., Aug. 08, 2018 (GLOBE NEWSWIRE) -- Nabriva Therapeutics plc (NASDAQ: NBRV), a clinical stage biopharmaceutical company engaged in the research and development of innovative anti- [...]

Leap Therapeutics Reports Second Quarter 2018 Business Update and Financial Results

08/08/2018 - 13:00

CAMBRIDGE, Mass., Aug. 08, 2018 (GLOBE NEWSWIRE) -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company developing targeted and immuno-oncology therapeutics, today reported a business update and financial [...]

ProQR Announces Financial Results for the Second Quarter of 2018

08/08/2018 - 13:00

LEIDEN, The Netherlands, Aug. 08, 2018 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR) (the “Company”), a company dedicated to changing lives through the creation of transformative RNA medicines for the [...]

Evogene Reports Second Quarter 2018 Financial Results

08/08/2018 - 13:00

Conference call and webcast, today at 9:00 am Eastern Time REHOVOT, Israel, Aug. 08, 2018 (GLOBE NEWSWIRE) -- Evogene Ltd. (NASDAQ, TASE: EVGN), a leading biotechnology company developing novel products for life science [...]

Pluristem Initiates Two Pivotal Phase III Studies in Israel

08/08/2018 - 13:00

Numerous Clinical Sites in Israel to join sites in the U.S. and Europe for Pivotal Phase III Studies of PLX-PAD Cell Therapy in the Treatment of Critical Limb Ischemia and Muscle Injury Following Hip Fracture HAIFA, [...]

BioNovelus Announces Marvin R Clark Leaving the Board of Directors, and Welcomes Michael D Goodman as New Treasurer and Member of Board of Directors

08/08/2018 - 13:00

Phoenix, Aug. 08, 2018 (GLOBE NEWSWIRE) -- / BioNovelus, Inc. (OTC Pink: ONOV) today announced that Marvin R Clark has stepped down from the Company's board of directors, and as Treasurer for personal reasons, effective [...]

Clearside Biomedical Announces Second Quarter 2018 Financial Results and Provides Corporate Update

08/08/2018 - 13:00

ALPHARETTA, Ga., Aug. 08, 2018 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company dedicated to developing treatments that restore and preserve vision for people with serious eye [...]

INSYS Therapeutics Reaches Agreement in Principle to Settle Department of Justice Investigation

08/08/2018 - 13:00

Provisional Financial Settlement Terms Are Consistent with Previous Public Statements and Disclosures PHOENIX, Aug. 08, 2018 (GLOBE NEWSWIRE) -- INSYS Therapeutics, Inc. (NASDAQ: INSY), a leader in the development, [...]

AC Immune Reports Second Quarter 2018 Financial Results and Corporate Update

08/08/2018 - 10:01

New total cash position of approximately CHF 210 million that is expected to extend cash runway to Q3 2021, excluding potential incoming milestones Financial position strengthened after Q2 close due to issuance of new [...]

“Grindeks” concludes land purchase agreement for innovation centre development

08/08/2018 - 09:42

JSC “Grindeks” announces, it has expanded its territory and acquired a plot of land with buildings located in Riga, Krustpils street 63 for the development of innovation centre. The 92 584-square-meter plot of land in [...]

Frankfurt’s Clearstream Banking Lifts Settlement Restrictions on Securities Active in Medical Cannabis

08/08/2018 - 09:30

VANCOUVER, British Columbia, Aug. 08, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) ( “ Veritas ” or the “Company”) is pleased to announce that Clearstream Banking, a major [...]

CORRECTION (UPDATED LINK): VIFOR PHARMA GROUP REPORTS STRONG H1 2018 RESULTS, RAISES FULL-YEAR GUIDANCE

08/08/2018 - 08:08

Strong financial performance in H1 2018 Three medium-term strategic growth drivers fully on track Strategic in-licensing deal concluded with Cara Therapeutics Inc. Net sales and EBITDA guidance for 2018 raised and [...]

Shire plc: Rule 2.9 Announcement

08/08/2018 - 08:00

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 8 August 2018 [...]

Motif Bio Announces Notice of Allowance for Two U.S. Iclaprim Patents with Expiration in 2037

08/08/2018 - 08:00

NEW YORK, Aug. 08, 2018 (GLOBE NEWSWIRE) -- Motif Bio plc (AIM/NASDAQ: MTFB) ("Motif Bio" or the "Company"), a clinical-stage biopharmaceutical company specialising in developing novel antibiotics, today announced that [...]

GENEDRIVE PARTNERS WITH FIND TO EVALUATE A MOLECULAR DIAGNOSTIC KIT FOR HEPATITIS C VIRUS IN DECENTRALISED SETTINGS

08/08/2018 - 08:00

GENEDRIVE PARTNERS WITH FIND TO EVALUATE A MOLECULAR DIAGNOSTIC KIT FOR HEPATITIS C VIRUS IN DECENTRALISED SETTINGS Evaluation studies of the Genedrive® HCV ID Kit will take place in Cameroon and Georgia Assay designed [...]

Novo Nordisk's operating profit decreased by 8% in Danish kroner and increased by 4% in local currencies in the first six months of 2018

08/08/2018 - 07:31

Sales decreased by 5% in Danish kroner and increased by 4% in local currencies to DKK 54.3 billion. Sales of Victoza® increased by 2% to DKK 11.7 billion (12% in local currencies). Sales of Saxenda® increased by 35% to [...]

Advance Notice: Reviewed Financial Statement's announcement for the period 30 June 2018

08/08/2018 - 07:29

EASTPHARMA LTD. London, 08 August 2018 - EastPharma (EAST LI) informs that it will be releasing its reviewed financial statements for the period 30 June 2018 and a review of its main subsidiary DEVA Holding's financial [...]